Option Care Health, Inc. $OPCH Shares Sold by Park West Asset Management LLC

Key Points

• Park West Asset Management LLC reduced its holdings in Option Care Health by 45.7%, selling 889,387 shares, bringing its total ownership to approximately $36.9 million.
• Multiple hedge funds increased their investments in Option Care Health significantly, with Northwestern Mutual Wealth Management raising its position by 1,492.9% during the first quarter.
• Option Care Health reported $1.42 billion in revenue for the recent quarter, exceeding estimates, and raised its earnings per share (EPS) guidance for FY 2025 to between $1.650-$1.720.

Park West Asset Management LLC decreased its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 45.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,056,804 shares of the company's stock after selling 889,387 shares during the quarter. Option Care Health accounts for approximately 3.0% of Park West Asset Management LLC's portfolio, making the stock its 13th largest holding. Park West Asset Management LLC owned 0.65% of Option Care Health worth $36,935,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in OPCH. Northwestern Mutual Wealth Management Co. lifted its position in shares of Option Care Health by 1,492.9% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock valued at $31,000 after buying an additional 836 shares in the last quarter. Brooklyn Investment Group lifted its position in shares of Option Care Health by 186.6% during the 1st quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock valued at $42,000 after buying an additional 780 shares in the last quarter. Public Employees Retirement System of Ohio lifted its position in shares of Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after buying an additional 332 shares in the last quarter. Bessemer Group Inc. lifted its position in shares of Option Care Health by 62.3% during the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after buying an additional 599 shares in the last quarter. Finally, Wealthquest Corp purchased a new position in shares of Option Care Health during the 1st quarter valued at approximately $66,000. Institutional investors and hedge funds own 98.05% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. JMP Securities increased their target price on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research report on Thursday, July 31st. Citigroup restated an "outperform" rating on shares of Option Care Health in a report on Thursday, July 31st. Finally, Barrington Research restated an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a report on Thursday, July 10th. Eight investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, Option Care Health currently has an average rating of "Moderate Buy" and an average target price of $35.75.

Option Care Health Stock Up 1.1%

Shares of OPCH opened at $29.09 on Friday. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The company has a market capitalization of $4.72 billion, a PE ratio of 23.27, a price-to-earnings-growth ratio of 1.75 and a beta of 0.82. The stock has a fifty day simple moving average of $29.29 and a two-hundred day simple moving average of $31.55. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. The firm had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The company's quarterly revenue was up 15.4% on a year-over-year basis. During the same period last year, the company earned $0.30 EPS. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, equities analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of the business's stock in a transaction that occurred on Wednesday, August 20th. The stock was purchased at an average cost of $27.15 per share, with a total value of $977,400.00. Following the transaction, the director owned 375,390 shares of the company's stock, valued at $10,191,838.50. This trade represents a 10.61% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Timothy P. Sullivan acquired 20,000 shares of the business's stock in a transaction that occurred on Thursday, August 21st. The shares were acquired at an average cost of $27.51 per share, with a total value of $550,200.00. Following the completion of the transaction, the director directly owned 49,229 shares in the company, valued at approximately $1,354,289.79. The trade was a 68.43% increase in their position. The disclosure for this purchase can be found here. 0.64% of the stock is currently owned by company insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.